4 research outputs found
The human Na<sup>+</sup>/H<sup>+</sup> exchanger 1 is a membrane scaffold protein for extracellular signal-regulated kinase 2
Background
Extracellular signal-regulated kinase 2 (ERK2) is an S/T kinase with more than 200 known substrates, and with critical roles in regulation of cell growth and differentiation and currently no membrane proteins have been linked to ERK2 scaffolding.
Methods and results
Here, we identify the human Na+/H+ exchanger 1 (hNHE1) as a membrane scaffold protein for ERK2 and show direct hNHE1-ERK1/2 interaction in cellular contexts. Using nuclear magnetic resonance (NMR) spectroscopy and immunofluorescence analysis we demonstrate that ERK2 scaffolding by hNHE1 occurs by one of three D-domains and by two non-canonical F-sites located in the disordered intracellular tail of hNHE1, mutation of which reduced cellular hNHE1-ERK1/2 co-localization, as well as reduced cellular ERK1/2 activation. Time-resolved NMR spectroscopy revealed that ERK2 phosphorylated the disordered tail of hNHE1 at six sites in vitro, in a distinct temporal order, with the phosphorylation rates at the individual sites being modulated by the docking sites in a distant dependent manner.
Conclusions
This work characterizes a new type of scaffolding complex, which we term a “shuffle complex”, between the disordered hNHE1-tail and ERK2, and provides a molecular mechanism for the important ERK2 scaffolding function of the membrane protein hNHE1, which regulates the phosphorylation of both hNHE1 and ERK2
Discovery, preclinical characterization, and early clinical activity of JDQ443, a structurally novel, highly potent, selective covalent oral inhibitor of KRASG12C
Covalent inhibitors of KRASG12C have shown antitumor activity against advanced/metastatic KRAS G12C-mutated cancers, though resistance emerges and additional strategies are needed to improve outcomes. JDQ443 is a structurally unique covalent inhibitor of GDP-bound KRASG12C that forms novel interactions with the switch II pocket. JDQ443 potently inhibits KRASG12C-driven cellular signaling and demonstrates selective antiproliferative activity in KRAS G12C-mutated cell lines, including those with G12C/H95 double mutations. In vivo, JDQ443 induces AUC exposure-driven antitumor efficacy in KRAS G12C-mutated cell-derived (CDX) and patient-derived (PDX) tumor xenografts. In PDX models, single-agent JDQ443 activity is enhanced by combination with SHP2, MEK or CDK4/6 inhibitors. Notably, the benefit of JDQ443 plus the SHP2 inhibitor TNO155 is maintained at reduced doses of either agent in CDX models, consistent with mechanistic synergy. JDQ443 is in clinical development as monotherapy and in combination with TNO155, with both strategies showing antitumor activity in patients with KRAS G12C-mutated tumors
Measurement of the branching fractions for Cabibbo-suppressed decays and at Belle
International audienceWe present measurements of the branching fractions for the singly Cabibbo-suppressed decays and , and the doubly Cabibbo-suppressed decay , based on 980 of data recorded by the Belle experiment at the KEKB collider. We measure these modes relative to the Cabibbo-favored modes and . Our results for the ratios of branching fractions are , , and , where the uncertainties are statistical and systematic, respectively. The second value corresponds to , where is the Cabibbo angle; this value is larger than other measured ratios of branching fractions for a doubly Cabibbo-suppressed charm decay to a Cabibbo-favored decay. Multiplying these results by world average values for and yields , , and , where the third uncertainty is due to the branching fraction of the normalization mode. The first two results are consistent with, but more precise than, the current world averages. The last result is the first measurement of this branching fraction
Measurement of branching fractions of and at Belle
We present a study of a singly Cabibbo-suppressed decay and a Cabibbo-favored decay based on 980 of data collected by the Belle detector, operating at the KEKB energy-asymmetric collider. We measure their branching fractions relative to : and . Combining with the world average , we have the absolute branching fractions: and . The first and second uncertainties are statistical and systematic, respectively, while the third ones arise from the uncertainty on . The mode is observed for the first time and has a statistical significance of . The branching fraction of has been measured with a threefold improvement in precision over previous results and is found to be consistent with the world average